Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Lebovitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $243.00 | 19.75% | $227 → $291 | Maintains | Buy | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $34.19 | 11.14% | $37 → $38 | Maintains | Buy | Get Alert |
| 05/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.90 | 36.97% | $389 → $382 | Maintains | Buy | Get Alert |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 10.53% | $94 → $91 | Maintains | Neutral | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.90 | 39.48% | $382 → $389 | Maintains | Buy | Get Alert |
| 03/06/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $44.79 | 51.82% | → $68 | Initiates | → Buy | Get Alert |
| 02/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $243.00 | -6.58% | $237 → $227 | Maintains | Buy | Get Alert |
| 10/27/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | -43.33% | $29 → $17 | Downgrade | Neutral → Sell | Get Alert |
| 10/10/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $243.00 | -4.12% | $266 → $233 | Maintains | Buy | Get Alert |
| 09/18/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | -3.33% | $55 → $29 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $243.00 | 9.47% | $265 → $266 | Maintains | Buy | Get Alert |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 110% | $70 → $63 | Maintains | Buy | Get Alert |
| 05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 133.33% | $67 → $70 | Maintains | Buy | Get Alert |
| 04/28/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 123.33% | $61 → $67 | Maintains | Buy | Get Alert |
| 02/24/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $243.00 | 9.05% | $270 → $265 | Maintains | Buy | Get Alert |
| 02/01/2022 | BPMC | Buy Now | Blueprint Medicines | $107.78 | -14.64% | $111 → $92 | Maintains | Equal-Weight | Get Alert |
